INTRODUCTION
Haemophilus ducreyi is a fastidious gram-negative bacillus that causes the sexually transmitted infection chancroid. There has been renewed interest in this pathogen and in chancroid since an association was demonstrated between genital ulcers and human immunodeficiency virus (HIV) infection. The state of our knowledge concerning the diagnosis and treatment of chancroid and the genetics, physiology, and pathogenesis of H. ducreyi was extensively reviewed in 1989 (5, 98) . Both reviewers concluded that our knowledge was limited and that additional studies were needed. In this article, we will summarize the progress that has been made during the past 5 years and highlight gaps in our knowledge of this interesting pathogen.
EPIDEMIOLOGY
Chancroid is a genital ulcerative disease. These diseases are common throughout the world and include syphilis, genital herpes, chancroid, lymphogranuloma venereum, and donovanosis. Chancroid is particularly common in Africa, Asia, and Latin America, where its incidence may exceed that of syphilis as a cause of genital ulceration (109, 116) . However, chancroid is considered an uncommon sexually transmitted infection in the United States. From data forwarded to the Centers for Disease Control and Prevention (CDC), the reported number of chancroid cases peaked in 1947 at 9,515 cases before begin-ning a decline, which lasted until the mid-1980s. During the 20-year period between 1965 and 1984, the number of reported cases averaged 925 a year (range, 455 to 1,416 cases). However, beginning in 1985, the number of reported cases of chancroid increased dramatically, with 4,986 cases reported in 1987 ( Fig.  1 ). Since 1987, the number of reported cases of chancroid has decreased steadily. Only 1,399 cases were reported to CDC in 1993 (34) .
Chancroid cases are not evenly distributed throughout the United States. Most cases are reported among minorities living in eastern cities and in the South. In 1989, five states (Florida, Georgia, Louisiana, New York, and Texas) accounted for 94.7% of the reported cases of chancroid; however, the same five states accounted for only 82.8% of the reported cases of chancroid in 1993 (Table 1) . This difference reflects a decrease in chancroid reports from these states coupled with an increase in areas where chancroid was formerly infrequently reported. Fourteen states did not report a single case of chancroid during the period from 1989 to 1993. Recent data suggest that chancroid is a common cause of genital ulcers in some areas of the United States. For example, H. ducreyi was detected in 37 of 101 consecutive men presenting at a New Orleans sexually transmitted disease (STD) clinic with genital ulcers (108) .
It is likely that chancroid has been underreported in the United States. Many states reported only culture-confirmed chancroid cases, in part because a standard surveillance definition for a clinically compatible case was not implemented until 1990 (31) . For surveillance purposes, a chancroid case may now be classified as either probable or confirmed. A probable case means the patient has clinically compatible symptoms, with one or more painful genital ulcers, and both (i) no evidence of Treponema pallidum infection by dark-field examination of ulcer exudate or by a serological test for syphilis performed at least 7 days after onset of ulcers and (ii) ulcers not typical of disease caused by herpes simplex virus (HSV) or a negative HSV culture. A case is confirmed when H. ducreyi has been isolated from a clinical specimen. However, the results of a recent survey of 115 STD clinics located in 32 states, Puerto Rico, and the District of Columbia (32) have indicated that culture medium for H. ducreyi was not always available and that these clinics had limited ability to differentiate among chancroid, syphilis, and genital herpes. Thus, in spite of the change in the case definition, chancroid cases are likely to be underreported. Future investigations, using state-of-the-art methods, are needed to elucidate the etiology of genital ulcers from different geographical sites.
The increase in the incidence of chancroid in the mid-1980s occurred at the same time that the incidence of primary and secondary syphilis increased among minority heterosexual men and women (34) . The increase in syphilis was associated with cocaine use in both men and women (57, 130) and, among men, with the exchange of drugs or money for sexual favors (130) . It was postulated that similar factors might also be responsible for the increase in chancroid. Recently, Martin and DiCarlo (93) reported that chancroid infection in male patients in New Orleans was strongly associated with crack cocaine use; however, drug use by the patient was really a marker for a more important risk factor: sexual exposure to a cocaineusing woman.
The persistence of chancroid in a population depends on several factors, which have been discussed in detail by Anderson (18) . These factors can be expressed mathematically by the equation R 0 ϭ ␤Dc, where R 0 is the reproductive rate, defined as the average number of secondary cases generated by one primary case in a susceptible population of defined density; ␤ is the average probability that the infection is transmitted per sexual partner contact per unit time; D is the average duration of infectiousness of an infected individual; and c is the average number of sexual partners per unit time. If R 0 Ͻ 1, the infection will not persist and no epidemic will occur. Alternatively, if R 0 Ͼ 1, the infection will persist and an epidemic will occur. Over and Piot (110) estimated that the probability of transmitting chancroid from an infected male to an uninfected female during a single sexual exposure was 0.35, whereas the probability of transmitting chancroid from an infected female to an uninfected male during a single sexual exposure was 0.30. The duration of infectivity was estimated to be 45 days (110) . The observation that some chancroid outbreaks in the United States have been associated with prostitution (21, 53) suggests that the number of sexual partners (c) is a critical factor in the spread of chancroid. This may also help to explain the association of chancroid with certain risk factors, such as crack cocaine and alcohol use (93) , since individuals who abuse cocaine or alcohol (17, 94, 143) have more sexual partners and are more likely to engage in high-risk sexual behavior (143) . STDs in general, and genital ulcerative diseases in particular, have been shown to be important risk factors in the heterosexual transmission of HIV (167) . Genital ulcerative diseases as a clinical syndrome or as an etiological diagnosis were a significant risk factor for HIV seroconversion in prospective and cross-sectional case-control studies, even when sexual behavior was controlled for (26, 79, 119) . The majority of these data come from studies performed in East African countries, such as Zaire and Kenya, where most genital ulcers are due to chancroid (118) . However, similar associations were found in studies conducted in West Africa and in the Caribbean (56, 115) . Two mechanisms have been proposed to explain how genital ulcers enhance the transmission of HIV. Chancroid and other genital ulcerative diseases could facilitate the transmission of HIV by increasing the shedding of virus through the ulcer. In fact, HIV has been detected in chancroidal ulcers (78, 120) . The presence of an ulcer could also increase susceptibility to HIV infection by disrupting the epithelial barrier and perhaps by increasing the number of HIV-susceptible cells at the point of entry. CD4 T lymphocytes have been identified in lesions caused by Treponema pallidum (52) and HSV (37) . Biopsy specimens of chancroidal lesions from persons experimentally infected with H. ducreyi revealed the presence of an infiltrate of T lymphocytes and macrophages in the dermis; the T lymphocytes expressed HLA-DR, indicating that they were activated (151) . The proportion of these cells that are CD4 lymphocytes remains to be determined.
CLINICAL FEATURES
The clinical features of chancroid and its varieties have been described previously (98) . However, several recent reports suggest that prior HIV infection can modify the appearance and clinical course of chancroid. HIV-infected men tend to have a greater number of ulcers than those who are not infected with HIV (163) , and those ulcers do not heal as readily. Quale et al. (123) reported the presence of a nonhealing penile lesion of 4 months' duration in a 31-year-old man infected with HIV. In addition, the patient had multiple nonhealing extragenital lesions on his leg and foot, which may have resulted from autoinoculation. An organism resembling H. ducreyi was isolated from the ulcer; however, the isolate was lost before confirmatory biochemical tests could be performed. The lesion responded to therapy with intramuscular (i.m.) ceftriaxone followed by oral erythromycin. No information on the extent of immunosuppression in the patient was given. HIV-infected patients may also have atypical lesions. Abeck et al. (1) reported an elevated perianal ulcer, which was highly indurated, of 4 weeks' duration in a 25-year-old HIV-seropositive man. H. ducreyi was isolated from the lesion; the lesion was also positive by dark-field microscopy for T. pallidum and negative by culture for HSV. The patient had a CD4/CD8 ratio of 1.3 and a CD4 count of 350/mm 3 . Thus, he was only mildly immunosuppressed.
Concurrent HIV infection appears to modify the patient's response to chancroid therapy. Tyndall et al. (163) reported that among HIV-seropositive men with chancroid, therapy with a single dose of 250 mg of ceftriaxone i.m. failed more often than among men who were HIV seronegative. The HIVinfected men were thought to have only mild immunosuppression. In another study, which evaluated the treatment of culture-confirmed chancroid (87) with a single oral dose of the quinolone fleroxacin, bacteriological failure occurred in 3 of 11 HIV-infected men (27%), compared with 1 of 26 HIV-seronegative men (5%). In both of these studies, antibiotic resistance did not have a role in treatment failures, as the H. ducreyi isolates were highly susceptible to ceftriaxone (163) and fleroxacin (87) . Thus, it is likely that other factors (e.g., immune status, pharmacokinetics, or the presence of a foreskin) are responsible for the high proportion of chancroid treatment failures among HIV-infected patients.
H. ducreyi has not been shown to cause systemic infection; however, extragenital lesions can occur and are thought to be the result of autoinoculation. It is interesting that disseminated H. ducreyi has not been reported, even in patients who are severely immunosuppressed by HIV infection. The relatively low optimum growth temperature (33 to 35ЊC) may preclude dissemination; however, further studies are needed to define the contribution of host immunity.
TREATMENT
CDC recommends the following regimens (33) for the treatment of chancroid: azithromycin, 1 g orally in a single dose; ceftriaxone, 250 mg i.m. in a single dose; or erythromycin base, 500 mg per os (p.o.) four times a day for 7 days. Amoxicillin, 500 mg, plus clavulanic acid, 125 mg, p.o. three times a day for 7 days, and ciprofloxacin, 500 mg p.o. two times a day for 3 days, are alternative regimens. These alternative regimens have not been evaluated as extensively as the recommended regimens. The primary treatment recommended by the World Health Organization is erythromycin (500 mg p.o. three times a day for 7 days), with ceftriaxone (250 mg i.m. in a single dose), ciprofloxacin (500 mg as a single oral dose), spectinomycin (2 g i.m. as a single dose), and trimethoprim-sulfamethoxazole (TMP-SMX) (two tablets twice a day for 7 days) as alternative recommended regimens (170) . Fleroxacin (400 mg as a single oral dose) has also been shown to be effective in the treatment of culture-proven chancroid (117, 164) . Single-dose therapy (61, 117, 163) is advantageous because it avoids problems with compliance; however, cost is a major consideration in developing countries, where chancroid is prevalent.
Several factors affect treatment efficacy. As mentioned above, concurrent HIV infection was found to increase the probability of treatment failure following a single dose of either ceftriaxone (250 mg i.m.) or fleroxacin (400 mg p.o.) (87, 163) ; however, increasing the duration of fleroxacin treatment (400 mg orally once a day for 5 days) appears promising and should be studied further as a possible treatment regimen for HIV-infected men (164) . In these studies, treatment failure was not due to infection with an antibiotic-resistant strain. However, antimicrobial resistance is extensive in H. ducreyi (see below), which will affect the choice of treatment regimen.
Most isolates of H. ducreyi worldwide are susceptible to erythromycin, but strains for which the erythromycin MIC is 4 g/ml have been isolated in Singapore (146) and Thailand (75) . No resistance to ceftriaxone has been reported. Resistance to amoxacillin-clavulanic acid is more common among ␤-lactamase-negative strains than among ␤-lactamase-positive strains (75) . One strain with a ciprofloxacin MIC of 2.0 g/ml has been isolated in Thailand (75); however, quinolone resistance does not appear to be widespread. H. ducreyi resistance to TMP-SMX has been reported in Rwanda (166) ; the prevalence of resistant strains increased from 9% (2 of 23) in 1988 to 48% (34 of 71) of strains examined in 1991. All of the TMP-SMXresistant isolates were resistant to TMP (MIC, Ͼ4.0 g/ml). Strains resistant to TMP-SMX have also been isolated in the United States (75), Thailand (75) , and Kenya (117) . These data suggest that TMP-SMX, and possibly amoxacillin-clavulanic acid, should no longer be recommended for the treatment of chancroid. The prevalence and spectrum of antimicrobial resistance in H. ducreyi demand that caution should be exercised when advocating widespread use of an antibiotic for the treatment of chancroid unless clinical isolates are routinely monitored for resistance.
DIAGNOSIS

Culture Methods
Culture. H. ducreyi is a fastidious microorganism which is difficult to isolate from genital ulcer specimens (98) . A number of factors may be responsible for the reported difficulty in isolating H. ducreyi on selective medium. The growth factor supplements that have been used (i.e., IsoVitaleX [BBL], Vitox [Oxoid] , and CVA [GIBCO]) are similar in composition; the only difference is that CVA enrichment contains 25.0 g of cysteine HCl per liter, whereas IsoVitaleX and Vitox contain 25.9 g of cysteine HCl per liter. Thus, it is unlikely that the growth factor supplement is responsible for differences in isolation rate (Table 2) . Differences in nutritional requirements between strains may be important, as investigators who have compared H. ducreyi growth on several media noted that isolates may be grown on some but not all media (40, 88) . The variation in the ability of a given medium to support the growth of H. ducreyi may be related to the nitrogen source (98) . Selective media for the isolation of H. ducreyi usually contain 3 g of vancomycin per ml to inhibit the growth of gram-positive bacteria (64) . Strains of H. ducreyi which are inhibited by 3 g of vancomycin have been observed in outbreaks of chancroid in the United States (73) . However, this observation needs to be confirmed in other laboratories.
Inhibitory medium components or inhibitory products of H. ducreyi metabolism have also been reported. Inhibitory lots of fetal bovine serum, which is often added to H. ducreyi medium and most likely serves to bind inhibitory substances (86) , have been reported (70) . The degree of inhibition appears to be related to the antibiotic susceptibility of the H. ducreyi strain and could be due to antibiotics transferred from the mother to the fetal calf. Nevertheless, this report points out the need to screen lots of fetal bovine serum for the absence of substances that can inhibit the growth of H. ducreyi. Fetal bovine serum can be replaced by either activated charcoal (86, 157) or bovine albumin (51); fetal bovine serum cannot be replaced by newborn calf serum (157) . The reason for the latter remains unknown. However, the ability to replace fetal bovine serum with 0.2% activated charcoal will markedly reduce the cost of these media and make them easier to prepare for use in developing countries. One caveat is that the effectiveness of charcoalcontaining serum-free media in isolating H. ducreyi from clinical specimens has not been extensively compared with the effectiveness of serum-containing media.
Another important factor is the patient population used for the evaluation of selective media for the diagnosis of chan- (Table 2) . MacDonald et al. (88) evaluated the sensitivity of culture for H. ducreyi for men with genital ulcer disease who had negative results by dark-field microscopy and no history of prior antimicrobial therapy. However, dark-field microscopy is difficult to perform, and its sensitivity varies with the stage of the ulcer (42) . In addition, H. ducreyi is sometimes isolated from lesions positive for T. pallidum by dark-field microscopy (38) . It is generally accepted that a combination of two media, e.g., GCHgS and MH-HB, is optimum for the isolation of H. ducreyi. However, no single study has used these media to compare patients with a clinical diagnosis of chancroid and those with lesions negative for T. pallidum by dark-field microscopy. The results from two other studies indicated that the use of a combination of GC-HgS and MH-HB for the isolation of H. ducreyi from men with a clinical diagnosis of chancroid had a sensitivity that varied between 70 and 84%, while a sensitivity of 64% was reported for men with dark-field-negative ulcers ( Table 2 ). These differences may not be significant in light of the variables discussed above. More recently, Johnson et al. (72) compared the results of culture (GC-HgS and heart infusion agar supplemented with fetal bovine serum, fresh rabbit blood, IsoVitaleX, and vancomycin [HI-FRB]) for 96 consecutive men with genital ulcers and no history of prior antimicrobial therapy with the results of a PCR assay for H. ducreyi. Compared with PCR, culture had a sensitivity of 71% (Table  2 ). This value probably more accurately reflects the sensitivity of culture in an unselected population of men with genital ulcers.
Transport medium. Culture media for the isolation of H. ducreyi are often not available in peripheral laboratories because they are expensive to prepare and have a limited shelf life. The need for culture media at these sites can be overcome by the use of transport media that will maintain the viability of H. ducreyi until it is inoculated onto selective media at a central laboratory. Recently, Dangor et al. (41) compared the survival of a recently isolated strain of H. ducreyi in Stuart's, Amies', and four newly formulated thioglycolate-hemin-based transport media containing various combinations of selenium dioxide, albumin, and glutamine. No viable H. ducreyi were recovered when the inoculated transport media were held at room temperature (ca. 20ЊC) for 1 day; however, after 4 days at 4ЊC, viable H. ducreyi were recovered only from thioglycolate-hemin-based media containing either selenium dioxide, glutamine, and albumin or glutamine and albumin. These new transport media were subsequently evaluated (41) by using specimens from 156 patients who had been clinically diagnosed with chancroid. By direct plating on two different selective media, 110 of 156 (71%) specimens yielded positive cultures; duplicate swabs placed in transport media and held at 4ЊC for 4 days yielded 117 (75%) positive cultures when the specimens were inoculated onto the same media. Although recovery appears to be enhanced, several points bear mentioning. First, contamination appeared to be reduced after 4 days at 4ЊC; seven specimens that were contaminated on direct plating yielded H. ducreyi from the transport medium. Holding specimens at 4ЊC for 4 days resulted in an additional seven positive specimens that were originally negative on direct plating; however, five specimens that were initially positive were contaminated after 4 days at 4ЊC and another two were negative. These differences could be due to sampling error, as multiple swabs were obtained from each patient. Nevertheless, the use of these transport media may be a viable alternative when selective media are unavailable, if a reliable source of refrigeration exists.
Nonculture Diagnostic Tests
Polyclonal and monoclonal antibodies. The development of assays for the direct detection of H. ducreyi in smears by immunofluorescence has been hindered, in part, by the poor specificity of polyclonal antisera and, until recently, by the unavailability of specific monoclonal antibodies (MAbs) (98). Denys et al. (46) prepared antiserum to H. ducreyi for use in an indirect immunofluorescence assay by immunizing rabbits intravenously with heat-killed cells. The use of an adjuvant was not mentioned. The polyvalent antiserum thus prepared had to be extensively absorbed with Haemophilus species to eliminate cross-reactivity. Even after absorption, it gave a moderate degree of fluorescence with various Haemophilus species, Staphylococcus aureus, and Bacteroides melaninogenicus. Since preimmunization sera were not obtained, it was not possible to assess whether cross-reacting antibodies were present prior to immunization. More recently, Odumeru et al. (105) immunized rabbits and mice with UV-killed cells of H. ducreyi emulsified in Freund's complete adjuvant. No reactivity with H. ducreyi, Haemophilus influenzae, or Haemophilus parainfluenzae was observed on immunoblots probed with preimmunization sera; however, substantial cross-reactivity was observed with whole-cell proteins from H. influenzae and H. parainfluenzae on immunoblots probed with rabbit or mouse anti-H. ducreyi antiserum. The cross-reactivity, which could be reduced by absorption with H. influenzae or H. parainfluenzae, was also apparent in a direct enzyme-linked immunosorbent assay (ELISA). It is also possible that the nature of the antigen or the immunization protocol may quantitatively or qualitatively affect the production of antibody to H. ducreyi. Finn et al. (58) prepared polyclonal antisera to H. ducreyi in rabbits by an immunization protocol, which involved subcutaneous inoculation of washed, live bacteria together with Freund's incomplete adjuvant, followed 2 weeks later by an i.m. injection of washed bacteria and then three daily intravenous inoculations of washed bacteria. The polyclonal serum thus obtained was evaluated by indirect immunofluorescence without prior absorption. H. ducreyi strains gave high immunofluorescence titers (160 to 1,280). The only cross-reactivity at a serum dilution of Ͼ1:20 was observed at a dilution of 1:80 with a strain of Bordetella pertussis. Antiserum prepared in this manner can potentially be used in antigen capture assays or in immunofluorescence assays. A number of MAbs that react with antigens of H. ducreyi have been described (Table 4) . Some of these MAbs appear to be species specific and to recognize surface-exposed determinants (e.g., 9D12, A4, B11, and D1). These MAbs may be suitable for direct detection of H. ducreyi in genital lesion smears. Karim et al. (74) evaluated an MAb (58) as an immunofluorescence reagent for the detection of H. ducreyi in genital lesion smears and in smears prepared from bubo aspirates from patients in Johannesburg, South Africa; Bangkok, Thailand; and Kuala Lumpur, Malaysia. Compared with culture, immunofluorescence had a sensitivity of 93% for ulcer specimens and 89% for bubo specimens. However, the specificity of immunofluorescence was only 63% for ulcer specimens and 56% for bubo specimens. The poor specificity likely reflects the insensitivity of culture performed on site.
Several MAbs react with epitopes on H. ducreyi that are also found on other bacteria (e.g., MAbs 3F11, 6B4, and 2C7). These MAbs will provide insight on structure-function relationships and help elucidate the role of cell envelope components in the pathogenesis of chancroid.
DNA probes. Parsons et al. (112, 113) reported the development of DNA probes for H. ducreyi. These investigators used high-titered polyclonal antiserum against formalin-killed H. ducreyi ATCC 33922 to screen an EcoRI H. ducreyi genomic library in gt11. Three DNA inserts coding for proteins that were recognized by the H. ducreyi antiserum were selected and subcloned into a pUC13 plasmid vector. The 32 P-labeled probes, designated pLP1, pLP4, and pLP8, reacted strongly with 16 strains of H. ducreyi; no reactivity was observed with T. pallidum, Neisseria gonorrhoeae, or HSV DNA. The probes easily detected 10 4 CFU of H. ducreyi; weaker reactions were observed with 4.9 ϫ 10 3 CFU, and negative reactions were obtained with 1.4 ϫ 10 3 CFU. The probes also detected the presence of H. ducreyi DNA in rabbit lesion exudates; however, three of four positive reactions were obtained from culturenegative specimens. pLP8 also reacted weakly with relatively high numbers of a Haemophilus sp. and Pasteurella sp. (3 ϫ 10 7 to 6 ϫ 10 7 CFU); however, negative reactions were observed at lower cell concentrations (10 5 to 10 6 CFU). Subsequent sequencing of the insert in pLP8 (114) revealed that it encoded H. ducreyi homologs of groE and groEL. These are highly conserved genes and may explain the hybridization observed with the Haemophilus sp. and Pasteurella sp.
Two H. ducreyi probes have been developed by Chui et al. (36) , based on published sequences of the 16S rRNA gene of H. ducreyi (48, 133) . Although these probes were specific for H. ducreyi, neither reacted with all strains of H. ducreyi that were tested. DNA probes do not appear to have the sensitivity necessary for detecting the presence of H. ducreyi in clinical specimens. However, DNA probes have been used successfully for confirming the identification of H. ducreyi isolates (157) .
PCR. PCR appears to offer a more sensitive and specific approach for the diagnosis of chancroid. Three PCR assays for chancroid have been developed. Chui et al. (36) used broad primers based on eubacterial 16S rRNA gene sequences to amplify a 303-bp sequence from members of the families Pasteurellaceae and Enterobacteriaceae. Using two H. ducreyispecific probes internal to this sequence, they obtained 100% sensitivity with 51 strains from six continents that were isolated over a 15-year period. The clinical utility of PCR was compared with that of culture by using 100 clinical specimens from men with genital ulcers consistent with a clinical diagnosis of chancroid. Swab specimens were transported to the laboratory in phosphate-buffered saline containing chenodeoxycholate (1 mg/ml). After extraction, the DNA was amplified by means of a PCR protocol that involved 25 cycles of amplification, followed by use of Southern blot hybridization to detect the PCR product. A sensitivity of 83% and a specificity of 67% relative to culture were obtained. The sensitivity could be increased to 98% after three rounds of 25 cycles; however, the specificity compared with that of culture decreased to 51%. Johnson et al. (71) developed a PCR assay with a pair of primers selected from the sequences of an anonymous fragment of DNA cloned from H. ducreyi. The 1,100-bp PCR product was detected on Southern transfers with a 32 P-labeled probe consisting of the entire cloned sequence. The specificity of the PCR assay was determined by using 118 isolates of H. ducreyi and 25 isolates belonging to related genera or organisms found in genital ulcers. No amplification was observed for any bacterium other than H. ducreyi with the exception of a single strain of H. parainfluenzae, which gave inefficient amplification of a 500-bp fragment that did not hybridize with the 1,100-bp fragment amplified from H. ducreyi DNA. The utility of this assay was assessed by using specimens from 217 consecutive patients who sought treatment for genital ulcers at an STD clinic. HSV cultures, dark-field examination, and syphilis serology were performed for each patient. Specimens for PCR were collected in the phosphate-containing transport medium described by Dangor et al. (41) . Among a subgroup of 183 men whose genital ulcers contained a single etiologic agent (as determined by standard laboratory tests), PCR for H. ducreyi had a sensitivity of 65% and a specificity of 52% relative to culture. An 1,100-bp PCR product was amplified from the isolates of H. ducreyi obtained from culture-positive but PCRnegative ulcer specimens, indicating that sensitivity was not a problem. Further studies revealed the presence of Taq polymerase inhibitors in the preparations. The inhibitor was subsequently identified as P i (71, 72) . For a second series of 96 men with genital ulcers, Johnson et al. (72) used the sample collection and preparation protocol described by Chui et al. (36) and obtained a PCR sensitivity of 100% and a specificity of 84% compared with culture. The decreased specificity likely reflected the poor sensitivity of culture.
Orle et al. (108) reported on the development of a commercial multiplex PCR assay that permits the simultaneous amplification of DNA targets from H. ducreyi, T. pallidum, and HSV types 1 and 2. This assay was evaluated on genital ulcer specimens from 101 consecutive patients. With respect to chancroid, 24 of 25 culture-positive specimens were positive by PCR. An additional 11 PCR-positive specimens were culture negative. A confirmatory PCR assay utilizing a different target gene suggested that these were not false-positive results. When commercially available, this PCR assay should improve the diagnosis of chancroid and other genital ulcer diseases.
SUSCEPTIBILITY TESTING AND ANTIMICROBIAL RESISTANCE
The methods and the results of susceptibility studies have been reviewed in detail elsewhere (39, 98) . Most studies have used agar dilution; there has been little experience with disk diffusion susceptibility testing of H. ducreyi. Suffice it to say that susceptibility testing of H. ducreyi is not without problems. Dangor et al. (39) stated that the standards for antimicrobial susceptibility testing of fastidious organisms, including members of the genus Haemophilus (102), could not be applied to H. ducreyi because this organism requires hemin and supplementation with other nutrients for growth. Moreover, the cohesiveness of colonies and the agglutination of H. ducreyi in suspension make it difficult to standardize inoculum size. The following procedures have been proposed (39) until a standardized agar dilution method for MIC determinations for H. ducreyi is developed: (i) homogenize colonies of H. ducreyi in Mueller-Hinton broth; (ii) mix the cell suspension in a Vortex mixer or by sonication and allow the suspension to stand for 15 min to allow clumps of organisms to settle; (iii) adjust the optical density to that of a 0.5 McFarland barium sulfate standard; (iv) use an enriched Mueller-Hinton agar (Mueller-Hinton agar base supplemented with 0.1% glucose, 0.01% glutamine, 0.025% hemin, and 5% lysed horse blood; GC agar base may be substituted for Mueller-Hinton agar base) at an incubation temperature of 35ЊC in a humid atmosphere containing 5% CO 2 ; and (v) read plates after 48 h of incubation, with endpoints based on the lowest dilution of the antibiotic that yields no growth, two single colonies, or a fine, barely visible haze. For sulfonamide and TMP testing, a ca. 80% decrease in growth compared with that on the control plate may be used.
Geographical and temporal differences in antimicrobial susceptibilities have been observed. Many of the differences are due to the presence or absence of resistance plasmids (10, 100, 136, 137) . Plasmids which encode resistance, either separately or in combination, to sulfonamides (6, 169) , aminoglycosides (135, 169) , tetracyclines (8, 92, (126) (127) (128) , chloramphenicol (128) , and ␤-lactam antibiotics (25, 89, 90, 124, 154) have been identified in H. ducreyi (Table 5 ). These plasmids have been reviewed in detail elsewhere (98) . It is not unusual for a single H. ducreyi isolate to contain multiple resistance plasmids (45, 136, 137) , including more than one plasmid that confers resistance to ␤-lactam antibiotics. Strains containing both a 7.0-MDa TEM-1 ␤-lactamase plasmid and a 3.5-MDa ROB-1 ␤-lactamase plasmid have been isolated frequently in Thailand (90) .
The appearance of the class M tetracycline resistance determinant (Tet M) in H. ducreyi (126) is consistent with its presence in other genitourinary tract pathogens (127 (100, 137) . Some of these strains exhibited decreased susceptibilities to TMP, ciprofloxacin, and ofloxacin, suggesting the presence of chromosomally mediated resistance to these antimicrobial agents. MICs of penicillin G of 0.06 to 0.12 g/ml have been reported for some strains of H. ducreyi (20) , indicating in vitro activity by this class of antibiotics. However, increased MICs of penicillin G (0.25 to 1.0 g/ml) have been observed in ␤-lactamase-negative strains of H. ducreyi (100), which is consistent with the development of chromosomally mediated resistance. VOL. 8, 1995 CHANCROID AND H. DUCREYI 363
GROWTH AND NUTRITIONAL REQUIREMENTS
In Vitro Growth
Very little is known about the growth and nutritional requirements of H. ducreyi (7, 98) . Intercellular adhesion (98) is thought to be responsible for (i) the observation that colonies of this microorganism can be pushed intact across the surface of a solid medium and (ii) the clumps of cells that are observed in stained smears of H. ducreyi after growth on solid medium. The development of a defined liquid medium would facilitate studies on the growth and physiology of this microorganism. Recently, Dziuba et al. (51) studied the nutritional requirements of the type strain CIP 542 in a semidefined liquid medium by impedance technology. From the results of this study, they developed a simpler liquid medium, which contained the following (per liter): glucose, 10 g; NaCl, 6.67 g; NaH 2 PO 4 ⅐ H 2 O, 0.69 g; KCl, 0.20 g; MgSO 4 ⅐ 7H 2 O, 0.10 g; CaCl 2 , 0.10 g; L-glutamine, 0.10 g; L-serine, 0.10 g; and hemin, 0.005 g. The complex nitrogen source proteose peptone 3 (Difco), 2.0 g/liter, was required for growth; however, it could be replaced by either yeast extract (Difco), 2.0 g/liter, or gelatin (Difco), 17 g/liter. The utilization of these complex nitrogen sources was probably facilitated through the activity of a variety of aminopeptidases that are produced by this organism (98) . Both glucose and glutamine were also found to be required for the growth of H. ducreyi (51). The doubling time of H. ducreyi incubated at 33ЊC under ambient atmospheric conditions was 2.4 to 2.5 h, as estimated from impedance data. However, if bovine serum albumin (0.1%, wt/vol) was added to the medium to absorb toxic metabolic products, the generation time decreased to 1.8 h.
Totten and Stamm (157) developed a clear broth and plate medium which will be useful for physiologic and metabolic studies of H. ducreyi. The basal medium was identical in composition to GC agar base (Difco) and was supplemented with glucose and growth factors identical in concentration to those found in IsoVitaleX enrichment (BBL); fetal bovine serum (10%, vol/vol) and catalase (0.10 g/liter). A doubling time of 3 to 4 h for H. ducreyi was calculated from absorbance readings of tubes of broth medium incubated at 35ЊC under microaerophilic conditions. The difference in doubling times observed by Totten and Stamm (157) and Dziuba et al. (51) could be due to differences in the medium composition, incubation conditions, or the method by which growth was measured. Nevertheless, the range of generation times (1.8 to 4 h) is considerably slower than the range of generation times for other bacteria (103) but is consistent with the observation that 48 to 72 h of incubation are often needed to produce visible colonies on solid media (98) . Clumping of H. ducreyi during growth on solid medium makes quantitation difficult. Accurate quantitation of cell numbers is required for studies on the pathogenesis of this organism. Totten and Stamm (157) observed that H. ducreyi strains grown in the clear broth medium reached a density of 0.8 ϫ 10 8 to 2.5 ϫ 10 8 CFU/ml in 24 h and, when examined microscopically, appeared as single cells or chains; however, when grown on solid medium, the same strains appeared as single cells and clumps when viewed microscopically. Other methods have been used to reduce clumping. Alfa et al. (13) harvested the growth from plates into broth, let the larger clumps settle by gravity, and removed material from the top of the tube, which contained single cells and small clumps. Dangor et al. (41) found that suspending ca. 50 colonies of H. ducreyi in 2 ml of phosphate-buffered saline and passing the suspension through a 28-gauge needle 8 to 10 times was an efficient way to disrupt clumps of cells. This method should be performed in a biological safety cabinet to avoid aerosols (99).
Heme and Iron Previous studies have demonstrated that H. ducreyi is unable
to synthesize porphyrins or porphobilinogen from delta-aminolevulinic acid (7, 62) . More recently, Lee (84) observed that the addition of protoporphyrin IX together with various sources of iron could not replace the requirement for heme. These results suggest that H. ducreyi lacks the enzyme ferrochelatase, which catalyzes the synthesis of heme by inserting ferrous iron into protoporphyrin IX. H. ducreyi is not closely related to other hemin-dependent Haemophilus species (5, 98), which variably possess ferrochelatase (7). The results of earlier studies (7, 62) suggested that H. ducreyi required higher concentrations of heme than other Haemophilus species; 10 g of heme per ml was required to initiate growth, whereas 200 to 500 g of heme per ml was required for optimal growth. More recently, Dziuba et al. (51) observed that while 25 to 50 g of hemin per ml was required for growth on solid medium, only 5 g of hemin per ml was required for growth in liquid medium. These investigators postulated that decreases in the pH of the solid medium in the immediate area of a growing colony, resulting from the excretion of metabolic and end products, decreased the solubility of hemin and made higher concentrations necessary in order to compensate for the insoluble hemin.
The absence of ferrochelatase would explain the observations of Lee (84) , who was unable to detect the production of siderophores by H. ducreyi. He observed that only hemin or the heme-containing proteins bovine hemoglobin, human hemoglobin, and bovine catalase (but not equine cytochrome C 111 ) were capable of serving as the sole source of exogenous iron for the growth of H. ducreyi. Hemoglobin and heme, complexed with haptoglobin and serum albumin, respectively, could also be used as a source of iron. However, neither human transferrin, human lactoferrin, nor FeCl 3 would support the in vitro growth of this microorganism.
The mechanism by which H. ducreyi acquires iron from catalase and hemoglobin is unknown. However, from observations in other systems, it is likely that catalase and hemoglobin interact with the cell surface of H. ducreyi (97) and that the intact hemin molecule is internalized. Heme is associated through hydrogen bonding to hemoglobin and catalase (59), but it is covalently bound in cytochrome c. Thus, the ability of hemecontaining proteins to serve as sources of heme appears to be correlated with the noncovalent attachment of heme.
The iron (heme) sources utilized by H. ducreyi (84) are primarily intracellular. H. ducreyi may gain access to these sources by cell invasion (83) or through the activity of a hemolysin (111).
Selenium
Slootmans et al. (145) examined compounds that might improve the selectivity of the primary isolation medium for H. ducreyi. They observed that sodium selenate (MIC for 90% of strains [MIC 90 ] ϭ 4 g/ml) but not potassium selenite (MIC 90 ϭ 500 g/ml), selenomethionine (MIC 90 ϭ 750 g/ml), or selenocystamine (MIC 90 ϭ 64 g/ml) markedly inhibited the growth of H. ducreyi under ambient atmospheric conditions. Subinhibitory concentrations of selenium appeared to promote the growth of H. ducreyi. Vanden Berghe (165) observed that, under microaerophilic conditions, sodium selenite (0.1 g/ml) added to a medium comprised of Mueller-Hinton agar, hemin, glutamine, and bovine albumin stimulated the growth of H. ducreyi. However, Dziuba et al. (51) observed that the presence of sodium selenite in a liquid medium incubated under ambient atmospheric conditions did not stimulate the growth of H. ducreyi CIP 542. The reasons for these differences are unknown.
STRAIN TYPING
Previous studies which used sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) of outer membrane proteins, immunofluorescence, and enzyme profiles to phenotypically characterize strains of H. ducreyi were discussed in a previous review (98) . H. ducreyi has very limited biochemical activities that can be used to characterize individual strains. The development of a typing system with a high degree of discrimination would have broad applicability to studies on H. ducreyi. Such a typing system could address questions concerning the geographical distribution of strains and mode of transmission, discriminate between treatment failure and reinfection, identify strains of differing virulence, and provide a means to study the genetic diversity of this interesting pathogen.
Ribotyping
Ribotyping is based on restriction fragment length polymorphisms of rRNA genes, which are highly conserved and are usually present in multiple copies on the genome. Sarafian et al. (139) examined the HindIII and HincII banding patterns (ribotypes) of 44 strains after separating the fragments by agarose gel electrophoresis, transferring them to a nylon membrane, and hybridizing them with a 32 P-labeled probe of 16S and 23S RNA from Escherichia coli. HindIII digests yielded eight ribotypes, whereas HincII digests yielded four ribotypes. Further studies on 132 strains from various geographical areas increased the number of HindIII ribotypes to 12 and the number of HincII ribotypes to 5 (138) . The feasibility of using ribotyping for epidemiologic investigations of chancroid was suggested by the finding that four HincII and five HindIII ribotypes were observed among 14 H. ducreyi isolates collected during a 1-month period in Kenya, where chancroid is endemic.
Brown and Ison (23) used a digoxigenin-labeled cDNA probe prepared from E. coli 16S and 23S rRNA to circumvent the problems associated with using 32 P-labeled probes. They identified 10 HindIII ribotypes and three HincII ribotypes among 30 strains of H. ducreyi from diverse geographic areas. However, maximum discrimination among these strains was obtained with BstEII and BglII, which yielded 7 and 10 ribotypes, respectively. Both studies (23, 139) found that ribotyping was reproducible and that it discriminated among strains of H. ducreyi.
Rossau et al. (133) were isolated from patients who had recently traveled to Los Angeles, Korea, or El Salvador. The HindIII-2 strains could be further differentiated on the basis of their plasmid profile; the strains isolated from the three patients who reported travel to Los Angeles contained a 5.7-MDa plasmid, whereas the strain isolated from the patient who traveled to Korea contained 1.9-, 2.6-, 2.9-, and 3.2-MDa plasmids. This plasmid pattern is similar to that observed in strains isolated in the Far East (136) . Four ribotypes appeared to be acquired locally. The most interesting feature of this investigation was the finding of more than one strain of H. ducreyi, as defined by ribotype, with evidence indicating that some strains were acquired during travel outside the San Francisco area. In contrast, during a large outbreak in Orange County, California, all strains were found to possess a common 3.2-MDa plasmid and were presumed to represent a single strain (21) . However, a retrospective analysis of 28 isolates from this outbreak revealed the presence of two HindIII ribotypes, suggesting that more than one strain may have been involved in this outbreak (139) .
Plasmid Analysis
Plasmid profiles have been used to gain insight into the distribution and extent of temporal changes in H. ducreyi strain populations in the United States (137) . (60) . Plasmids may also be lost or transferred by conjugation (98) . Thus, plasmid profiles should be used in conjunction with another typing system (e.g., ribotyping) to provide additional discrimination (60).
Immunotyping
Roggen et al. (130) (23, 139) remains to be determined.
Lectin Agglutination
Because lectins have the ability to bind to a wide variety of microbial components that contain either simple or complex carbohydrates, they can be used to differentiate between strains of bacteria on the basis of variations in cell surface carbohydrates. Korting et al. (77) tested the ability of 43 H. ducreyi isolates from geographically diverse areas to agglutinate with a commercially available panel of 14 lectins (E. Y. Laboratories, San Mateo, Calif.) of known specificity. Each strain reacted with at least two lectins, and the majority reacted with more than five lectins. Among the strains tested, 20 different agglutination patterns were observed. Schalla and Morse (140) examined 63 isolates of H. ducreyi obtained from outbreaks in California, Georgia, New York, and Massachusetts, using the same commercially available lectin panel; the specificity of the agglutination reaction was assessed with specific carbohydrates. The isolates fell into one of two agglutination patterns, based on reactivity with the Griffonia simplicifolia II lectin; 57% of the isolates agglutinated with this lectin, and 43% of the isolates did not. There was no relationship between agglutination pattern and geographic location. In contrast to the results of Korting et al. (77) , no agglutination was observed with the lectins of Dolichos bifloris, Ulex europaeus I, and Lotus tetragonolobus. Schalla and Morse (140) also noted that agglutination with lectins from Lens culinaris and Phaseolus vulgaris could not be inhibited with specific carbohydrates and was due to nonspecific clumping of the organisms. Korting et al. (77) reported that most of their isolates were agglutinated by these lectins; however, specificity controls were not included in this study. Lectin typing of H. ducreyi is of doubtful value, based on limited ability to discriminate between isolates, nonspecific agglutination reactions, and the absence of data concerning the stability of the carbohydrate-containing cell surface markers.
HUMAN IMMUNE RESPONSE AND SEROLOGY
Delayed-type hypersensitivity to H. ducreyi antigens and the complement fixation test were formerly used as aids in the diagnosis of chancroid (67, 76) . However, their poor sensitivity and specificity preclude their current use in diagnosis. Increased knowledge of the antigenic composition of H. ducreyi and the human immune response to infection has led to the development and evaluation of serologic tests for chancroid (Table 6 ). However, it is difficult to compare the results obtained with these tests because each test is different. Table 6 shows that strains as well as antigen preparations, sorbents, solid phases, serum dilutions, immunoglobulins (Igs) measured, development time and temperature, and the chromogen differed between assays. These assays have not been compared against one another with the same serum specimens. Nevertheless, some general conclusions can be derived from these studies. Circulating IgG (47, 101, 131, 141) , IgM (47, 131, 141) , and IgA (131) are present in patients with culture-confirmed chancroid. The specificity of these tests is improved by the removal of cross-reacting antibodies by absorption (14, 15, 47, 131) ; the H. ducreyi-specific antibodies are to the outer membrane protein (14, 131) and lipooligosaccharide (LOS) (14) antigens. A number of factors which affect the sensitivity of these tests and render their use in diagnosis problematic have been identified. The sensitivity of the test is reduced with acute-phase serum specimens (47) and in younger patients (131) ; however, sensitivity is increased with increased duration of infection (131) . The sensitivity of the test is also antigen dependent (14, 15, 101, 131) . The anti-H. ducreyi immune response remains elevated for extended periods of time (15); this is due almost exclusively to IgG. This extended antibody response will affect the performance (i.e., positive predictive value) of these assays in populations with a high prevalence of chancroid. HIV infection also affects the test performance; enhanced specificity of IgG and sensitivity of IgM assays for anti-H. ducreyi antibodies have been observed with serum specimens from HIV-positive patients (47) . These assays have been used successfully to measure the prevalence of chancroid in 366 TREES AND MORSE CLIN. MICROBIOL. REV.
various individuals or groups to target and evaluate control efforts, as part of larger interventions designed to reduce the transmission of HIV.
MODELS FOR THE STUDY OF H. DUCREYI PATHOGENESIS In Vitro Studies
Numerous in vitro models have been used to study H. ducreyi pathogenesis (Table 7) . Alfa (11) compared the ability of H. ducreyi to cause a cytopathic effect (CPE) on adult foreskin cells (FS2-3, a primary cell line consisting mainly of fibroblasts) and human lung carcinoma cells (A549, a transformed cell line). Microscopic examination revealed that H. ducreyi formed ''fungus-like'' microcolonies on the FS2-3 cells but did not appear to invade these eukaryotic cells. Both H. ducreyi strains R018 and 35000 produced CPE on FS2-3 cells; no CPE was observed when H. influenzae and the ''avirulent'' H. ducreyi strain CIP542 were incubated with FS2-3 cells under similar conditions. None of the strains examined produced CPE on A549 cells. In another study, Alfa et al. (13) evaluated the attachment of ''virulent'' versus ''avirulent'' strains to human foreskin cell cultures by using 125 I-labeled H. ducreyi. The results showed that the virulent H. ducreyi strain 35000 attached to human foreskin cells at significantly higher levels, at both 22 and 35ЊC, than did the avirulent strain A77. Microscopic examination of the cell cultures suggested that H. ducreyi penetrated between the cultured foreskin cells; however, invasion of the cells was not evident. This group has also recently described the use of a chemiluminescent ribosomal probe method for determining the level of attachment of H. 
a T, transformed cell line; Nt, nontransformed cell line. b NT, not tested. VOL. 8, 1995 CHANCROID AND H. DUCREYI 367 ducreyi to eukaryotic cells (12) . Lagergard et al. (82) used viable cell counts and radioassays to examine the ability of 10 H. ducreyi strains to attach to HEp-2 and HeLa cells. All 10 strains were observed to attach to both cell lines, with peak adherence occurring at 2 to 3 h. Gentamicin was added to HEp-2 cells in order to distinguish between attachment and invasion. The survival of a small percentage of the inoculum after gentamicin treatment suggested that some of the bacteria may be intracellular. These authors also observed eukaryotic cell death following prolonged incubation with H. ducreyi, suggesting that a cytotoxic product was being released by the bacteria. Of the strains tested, six exhibited high levels of attachment to HFECs and two strains exhibited low levels of attachment. The strains that exhibited low levels of attachment were also avirulent in a rabbit infection model. The strain with the highest level of attachment was observed to invade the HFECs by ingestion into vesicles followed by release into the cytoplasm.
A recent study by Brentjens et al. (22) determined that H. ducreyi also binds to cultured human keratinocytes. After 2 h, 15 to 23% of the H. ducreyi inoculum was bound to the cell monolayer, compared with less than 1% for E. coli or Moraxella catarrhalis. This binding may be relevant to pathogenesis, since keratinocytes are probably the first host cells encountered by H. ducreyi.
In Vivo Studies
For many years, the standard animal model for determination of H. ducreyi virulence was the rabbit intradermal model (49, 55) . This model has several drawbacks, with the most outstanding being that the lesions do not resemble those of human chancroid. In recent years, studies have focused on developing better animal models that would be suitable for the in vivo study of H. ducreyi pathogenesis.
In 1988, Tuffrey et al. (161) reported that a mouse model of H. ducreyi infection had been developed in which pustules and ulcers similar to those seen in human infection were produced. However, later studies (162) showed that these lesions were formed following the injection of either viable or heat-killed H. ducreyi or with N. gonorrhoeae, which suggests that the lesions were not produced specifically by viable organisms or by H. ducreyi. Campagnari et al. (29) also observed that both viable and heat-killed bacteria produced lesions in rabbits as well as in mice, although viable organisms could not be isolated from the site of inoculation. Intradermal injection of 20 g of purified LOS from either H. ducreyi or N. gonorrhoeae produced lesions in rabbits that were histologically similar to those produced following the injection of viable or heat-killed bacteria (29) . Lagergard (80) also observed that intradermal injection of H. ducreyi LOS produced lesions in both mice and rabbits, although the amount of LOS required to consistently produce ulceration was approximately 200 g.
Trees et al. (159) adapted the chambered mouse model developed by Arko (19) to study H. ducreyi pathogenesis. Subcutaneous polyethylene chambers implanted in mice were inoculated with various strains of H. ducreyi. Growth of H. ducreyi occurred within the chambers, with some mice maintaining the infection for as long as 4 months. No dissemination of H. ducreyi from the chamber was observed. When this model was used, variation in H. ducreyi proteins during in vivo growth was observed (160).
Purcell et al. (121) postulated that the rabbit's high body temperature might prevent the in vivo growth of H. ducreyi, which has an optimum temperature for growth of 33 to 35ЊC. Rabbits that were housed at 15 to 17ЊC in order to reduce skin temperature developed necrotic lesions following the intradermal inoculation of 10 5 CFU of H. ducreyi. Animals that were housed at ambient temperatures (23 to 25ЊC) did not develop lesions when inoculated intradermally with the same concentration of H. ducreyi. Lesion formation was dependent on H. ducreyi viability, and live organisms could be recovered from the lesions. Histopathologic examination of lesions demonstrated that the infection evolved from acute inflammation to abscess formation. Although the lesions observed were not identical to those seen in humans with chancroid, this model represents a marked improvement over previous rabbit models.
Recently, Totten et al. (156) developed a primate model to study chancroid pathogenesis. In this study, adult pigtailed macaques (Macaca nemestrina) were inoculated with 10 7 to 10 8 CFU of H. ducreyi. The sites of inoculation were the foreskin for male macaques and the vaginal labia for female macaques. Male macaques developed lesions that were similar in appearance and progression to those seen in human chancroid, with ulcers developing in 6 to 12 days. Viable H. ducreyi could be isolated for up to 20 days, and humoral antibodies, as assessed by Western blotting, were detected beginning 1 week after infection. Antibodies reacting to proteins with similar migration, as shown by SDS-PAGE and immunoblotting, have been detected in humans (98) . None of the female animals that were inoculated with H. ducreyi developed visible ulcers and therefore were not evaluated for development of humoral antibodies. This lack of ulcer formation may be due to differences in the epithelium between males and females. The possibility of asymptomatic infection suggests that serologic studies should also be performed in the female macaques. Nevertheless, this model appears to be useful for the study of H. ducreyi pathogenesis in males.
Human Studies
There have been no human challenge studies with H. ducreyi for almost 40 years (43) . Recently, Spinola et al. (151) reported a study whose goal was to develop a safe and reliable H. ducreyi infection model in humans. Four volunteers were inoculated, by means of a multitest applicator, on the exterior surface of the upper arm. Three subjects received 10 4 to 10 6 CFU of H. ducreyi 35000, and the fourth subject received 10 5 CFU of live and heat-killed H. ducreyi. Lesions developed at all sites that received an inoculum of 10 5 CFU or greater and were mildly painful (Fig. 2) . Both viable bacteria and abraded skin were required for lesion formation. Lesions also developed in two subjects who were rechallenged 2 months after the initial in- 368 TREES AND MORSE CLIN. MICROBIOL. REV.
fection. Fever, lymphadenopathy, or dissemination of the infection did not develop in any of the subjects. Viable H. ducreyi cells were isolated from 10 of 12 biopsy specimens taken from the lesion area, although the number of bacteria recovered varied greatly. Histologic examination of lesion biopsy specimens revealed an infiltration of T cells, macrophages, and reactive endothelial cells. Western blotting revealed no evidence of a humoral immune response to either H. ducreyi proteins or LOS after primary or secondary infection. The use of a lower inoculation dose allowed patients to be infected for 2 weeks; however, the absence of a humoral immune response and the nature of the cellular infiltrate remained unchanged (147) . This model should prove useful in studying the interactions of H. ducreyi and human skin cells during the initial stages of infection.
POTENTIAL VIRULENCE FACTORS Pili
Until recently, it was thought that H. ducreyi did not possess pili. However, studies by Spinola et al. (148) have demonstrated that H. ducreyi does have pili, which appear as very fine surface appendages that are morphologically different from the pili found on N. gonorrhoeae. Pili were observed on all 12 H. ducreyi strains examined. Pilus expression was not readily lost during in vitro passage; however, pilus variation in vivo has yet to be studied. Pili have been purified from H. ducreyi, and after dissociation, the pilin monomer was found to have a molecular mass of 24 kDa in all strains examined (148) . The pilin receptor on host cells has not been identified.
Lipopolysaccharide
The lipopolysaccharide of H. ducreyi lacks the repeating O-antigens that are characteristic of enteric organism lipopolysaccharide. It is similar in size and structure to other mucosal pathogens, with a molecular mass of 3.5 to 6 kDa (91), and thus is more properly referred to as an LOS. Following intradermal injection, H. ducreyi LOS produces skin abscesses in rabbits, which are comparable in size to those produced by N. gonorrhoeae LOS and larger than those produced by H. influenzae or E. coli lipopolysaccharide (29) . This tissue destruction suggests that H. ducreyi LOS may play a role in the pathogenesis of chancroid.
LOS may also play a role in the evasion of the host immune response by H. ducreyi. MAb 3F11 binds to H. ducreyi LOS on Western blots (95) . The epitope recognized by MAb 3F11 is Gal134GlcNAc, which is also present in paragloboside, a glycosphingolipid precursor of the major human blood group antigen and of some gangliosides on human cells. This suggests that antigenic mimicry may enable H. ducreyi to evade certain host immune responses. The terminal Gal134GlcNAc of gonococcal LOS can be sialylated, converting a serum-sensitive organism to one that is serum resistant, providing the organism with an additional mechanism to counteract host defenses (92) . It has recently been shown that H. ducreyi LOS is sialylated in a similar fashion (96) .
Melaugh et al. (95, 96) determined that the LOS structure of H. ducreyi 35000 was Gal134GlcNAc134Gal134Hep13 6Glc13(Hep13Hep13) 3,4Hep133-deoxy-D-manno-octulosonic acid (Kdo), with the reducing terminal Kdo existing in an anhydro form. More recent studies (96) indicated the presence of additional LOS glycoforms which resulted from the truncation or elongation of the major LOS form. Schweda et al. (142) determined the LOS structure from two additional strains of H. ducreyi. The LOS from strain ITM 2665 had a structure similar to that described for strain 35000. The structure of the LOS from strain ITM4747 was much simpler: Gal134Glc13 (Hep132Hep13) 3,4Hep3Kdo. This structure is very similar to that of the LOS from the nontypeable H. influenzae 2019. The proposed structures of H. ducreyi LOS are depicted in Fig.  3 .
Recently, Campagnari et al. (27) obtained H. ducreyi LOS variants by selection for resistance to killing by Pseudomonas aeruginosa pyocins. One pyocin-resistant isolate produced a set of LOS molecules that were truncated in size compared with the LOS pattern of the wild-type strain. The LOS of this variant H. ducreyi strain no longer bound MAb 3F11 because of the loss of the terminal lactosamine, as demonstrated by immunologic and mass spectrometric techniques. LOS preparations from the variant strain also lacked sialic acid compared with LOS preparations from the wild-type strain, further supporting the hypothesis that the terminal lactosamine acts as a site for sialyation of H. ducreyi LOS (96).
Iron-Regulated Proteins
A recent study by Lee (84) demonstrated the presence of four new proteins with masses of 40.5, 45.5, 50, and 65 kDa when H. ducreyi was grown under iron-limiting conditions. However, because of the heme requirement of H. ducreyi, these proteins may be upregulated by heme restriction instead of by iron restriction. Because of this heme requirement and the lack of any observable siderophores, Lee (84) proposed the presence of a heme receptor, which has yet to be identified. Another study (3) demonstrated that, when grown under conditions of iron limitation, H. ducreyi produced new proteins in the range of 43 to 160 kDa. The number and molecular masses of these new proteins varied among the four strains examined. Examination of electron micrographs revealed that organisms grown under conditions of iron limitation possessed an enlarged periplasmic space compared with bacteria grown under iron-replete conditions. VOL. 8, 1995 CHANCROID AND H. DUCREYI
Cytotoxins and Hemolysins
The question of whether H. ducreyi produces a cytotoxin(s) and the role that such a cytotoxin may play in chancre formation has been the subject of several studies (Table 7) . Abeck et al. (2, 4) reported that filtrates from cultures of H. ducreyi did not contain extracellular enzymes, such as protease, elastase, lecithinase, lipase, collagenase, or IgA1 protease, which have been associated with virulence in other bacteria. In addition, culture filtrates had no cytotoxic activity against cultured Vero cells or human keratinocytes. Hollyer et al. (69) were also unable to detect the presence of extracellular H. ducreyi cytotoxins; CPE required either attachment or direct contact between H. ducreyi and the HFF cells. However, Purven and Langergard (122) observed cytotoxic activity against HEp-2 and HeLa cells. Cytotoxic activity was present in culture supernatants and preparations of sonicated or osmotically lysed cells. The cytotoxic effect was evident within 24 h and was heat and pronase sensitive. The toxic effect could be removed by incubating preparations with the target cells, which suggests that the putative cytotoxin was binding to the eukaryotic cells. No cytotoxic activity was seen against Vero or keratinocyte cell cultures. Rabbits immunized with H. ducreyi sonicates developed antibodies that neutralized the putative cytotoxin (81) . Sonicates of H. ducreyi strains that did not produce the putative cytotoxin were unable to induce neutralizing antibodies. Preimmune sera as well as sera against other gram-negative bacteria were unable to neutralize the putative cytotoxin. The production of hemolysins by H. ducreyi has been reported (84, 104) . However, a recent study by Palmer et al. (111) was the first to address this issue in detail. Hemolytic activity is a property common to a number of H. ducreyi strains. The hemolysin lysed erythrocytes from various mammalian sources; however, it was most active against horse erythrocytes and, to a lesser extent, against erythrocytes from rabbits, humans, and sheep. The hemolytic activity was sensitive to heat and protease treatment and was detected only in whole cells and not cell washes, sonicates, or supernatants. Thus, the hemolytic activity appeared to be distinct from the putative cytotoxin(s) described above. The hemolysin has not been purified, and its erythrocyte receptor or substrate has yet to be identified.
Heat Shock Proteins
Heat shock proteins have been studied in a number of bacterial species and have been identified as a possible source of damage caused by cross-reactive antibodies and T cells (134) . The heat shock operon of H. ducreyi, groE, was analyzed by Parsons et al. (114) , who identified two adjacent open reading frames that exhibited a high degree of homology with the groE genes and GroES and GroEL proteins found in other bacteria. The two H. ducreyi genes groES and groEL encode predicted proteins of 10.3 and 57.8 kDa, respectively. Northern (RNA) blots demonstrated that growth of H. ducreyi at the optimum temperature (33ЊC) resulted in a high level of groE mRNA; heat shock, including the relatively small change from 33 to 37ЊC, provided a protective effect to H. ducreyi cells when they were rapidly chilled following growth at 33ЊC. Parsons et al. (114) (149, 150 ). An 18-kDa protein was observed in all strains of H. ducreyi examined. However, MAb 3B9, which was used to detect the 18-kDa protein, also bound to proteins of various sizes in other Haemophilus species. Sarkosyl insolubility and immunoelectron microscopy suggest that the 18-kDa protein was located in the outer membrane. The 18-kDa protein was not heat modifiable and did not exhibit phase variation during growth in vitro. A protein described as the major OMP (MOMP) of H. ducreyi had an apparent molecular mass of 39 to 42 kDa, depending on the strain examined (150) . The H. ducreyi MOMP could be modified with heat, contained cysteine residues, and was cationic at a pH of 8.0, suggesting that it was not a classic porin protein (usually among the most abundant proteins in gram-negative bacteria). The N-terminal amino acid sequence and total amino acid content of the H. ducreyi MOMP exhibited homology to the OmpA proteins of members of the families Enterobacteriaceae, Neisseriaceae, and Pasteurellaceae. The function of this protein has yet to be determined; however, it may play a role in the serum resistance of this organism (125, 168) .
GENETICS AND CLASSIFICATION
Very little is known about the genetics of H. ducreyi. Therefore, the use of molecular biological techniques to study this organism has been limited. The construction of isogenic mutants of H. ducreyi will be necessary in order to evaluate the effect of a particular cellular component on pathogenesis. Two recent studies have explored the use of electroporation as a means of transforming H. ducreyi. Leong et al. (85) transformed plasmid DNA from clinical isolates of H. ducreyi into the reference strains ATCC 27722 and CIP542. Optimal electroporation conditions yielded a transformation frequency of approximately 10
Ϫ4
. Two beta-lactamase plasmids, pCH138 (7 MDa) and pCH137 (3.2 MDa), were used to transform the recipient strain to ampicillin resistance. The plasmids remained extrachromosomal and retained their original size following transformation. The transformation frequency was DNA concentration dependent up to a concentration of 0.75 g/ml. Above this concentration, only a slight increase in transformation frequency was seen. Electroporation was effective with both broth-and plate-grown cells.
Hansen et al. (65) obtained ca. 10 6 transformants per g of DNA when electroporation was used to transform H. ducreyi with the shuttle vector pLS88. Both linear and circular donor DNAs were successfully electroporated into the recipient cell, and transformation frequency was only slightly affected by DNA concentration. Electroporation has also been used to construct isogenic mutants of H. ducreyi (65) . Two cloned H. ducreyi genes, which encoded surface-exposed proteins of 49 and 23 kDa, were inactivated by the insertion of antibiotic resistance cassettes and used to transform H. ducreyi. The transformation frequencies with these constructs were lower, 10 1 to 10 3 CFU/g of DNA, than that obtained with pLS88; the transformants no longer reacted with MAbs that bind to the 49-kDa and 23-kDa proteins. Homologous recombination of the inactivated genes into the H. ducreyi chromosome was verified by Southern hybridization.
The ability to transform mutated genes, with successful homologous recombination, should prove valuable in the study of the virulence properties of specific H. ducreyi components in the pathogenesis of chancroid.
The issue of codon usage in H. ducreyi was evaluated by Parsons et al. (114) . After analysis of the groES and groEL genes, it was determined that H. ducreyi used U-or A-rich codons 79% of the time. This figure is the same as that observed with H. influenzae and is much higher than the 45% reported for E. coli. As more genes from H. ducreyi are cloned, sequenced, and studied, additional information about the genetics of this organism will come to light.
The taxonomic position of H. ducreyi as a Haemophilus species has been questioned for a number of years. H. ducreyi was originally placed in the genus Haemophilus because of its requirement for hemin (X-factor) and a GϩC content that was within the accepted range for Haemophilus spp. Albritton et al. (9) used genetic transformation, while Casin et al. (30) used DNA hybridization and S1 nuclease treatment to demonstrate that H. ducreyi was unrelated to true haemophili such as H. influenzae. De Ley et al. (44) used DNA-RNA hybridization to separate H. ducreyi from other haemophili but continued to classify H. ducreyi in the family Pasteurellaceae. Sequencing of the 16S rRNA of the type strain CIP542 (133) and two additional strains (48) confirmed that H. ducreyi was a member of the Pasteurellaceae. H. ducreyi has been assigned to cluster 4, while the true haemophili were assigned to cluster 1 (48) . The groupings of the family Pasteurellaceae are very complex, and while H. ducreyi clusters differently from the true haemophili, renaming may have to wait until further investigation or reorganization of the entire family takes place.
DEFINITION OF H. DUCREYI VIRULENCE
One area of importance to the study of chancroid pathogenesis is a definition of virulence for H. ducreyi. Various criteria to differentiate between so-called virulent and avirulent strains of H. ducreyi have been described. Resistance to polymyxin B was reported to correlate with virulence in a rabbit model for chancroid (63) . However, when this association was reevaluated by using isogenic polymyxin B-resistant and polymyxin B-susceptible strains, there was no correlation between polymyxin B resistance and virulence (106) . Resistance to the bactericidal action of 50% pooled normal human serum and resistance to phagocytosis and killing by human polymorphonuclear leukocytes have been used as criteria for virulence and to differentiate between strains that vary in their LOS composition (106) . More recently, cell culture models have been used to differentiate between virulent and avirulent strains of H. ducreyi (11, 13, 82, 83) . Perhaps the most widely accepted criterion for H. ducreyi virulence is the ability of a given strain VOL. 8, 1995 CHANCROID AND H. DUCREYI 371 to produce a typical chancroidal lesion after intradermal inoculation into rabbits (55) . By this criterion, the H. ducreyi type strain CIP542 has been designated avirulent. However, a recent laboratory infection with strain CIP542 (158) has focused attention on the definition of virulence. The course of this infection resembled that of chancroid. CIP542 has also been shown to be virulent in a mouse subcutaneous chamber model (159) . Because of these observations, the definition of CIP542 as avirulent needs to be readdressed. In addition, the roles that antigenic and phase variation, colony variation, and extracellular products, such as hemolysins and cytotoxins, play in determining whether a strain of H. ducreyi is virulent or avirulent also deserve our increased attention.
AREAS FOR FUTURE CONSIDERATION
During the past 5 years, considerable progress has been made in the development of nonculture tests (i.e., PCR) and methods for strain identification. These methods should be used to address issues such as the prevalence of H. ducreyi in genital lesions, the role of asymptomatic carriers, and virulence differences among strains. PCR will also be useful in examining the etiology of genital ulcer disease in various geographic areas and in assessing the sensitivity of currently used diagnostic tests as well as the accuracy of a clinical diagnosis.
To further understand the pathogenesis of this interesting microorganism, additional studies are needed to identify and characterize the virulence factors of H. ducreyi and to elucidate the mechanism by which this microorganism causes the pathology associated with chancroid. A consensus is needed on a serological assay that can be used to assess the seroprevalence of chancroid in various populations. Standardized methods for performing agar dilution and disk diffusion antimicrobial susceptibility tests on H. ducreyi are needed. The propensity that H. ducreyi has shown for acquiring resistance plasmids from other microorganisms suggests the need for surveillance to ensure the efficacy of currently used treatment regimens. More studies are also needed on the physiology and metabolism of H. ducreyi; the results of such studies will be important in the development of better culture media. Finally, issues surrounding the taxonomic status of H. ducreyi should be resolved.
